In 2024, Sera completed the PRIME trial. Substantial reductions were observed in neonatal morbidity, length of stay, NICU admissions and NICU length of stay. Data analysis suggested that 41 screenings ...
2 nd published peer reviewed paper in the last month supporting the use of geneType, on the back of the ASX release dated February 9, 2023. Utilised a prospective cohort of more than 200,000 women ...
Large prospective study to evaluate a non-invasive prenatal screening test Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a ...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch ...
Add Yahoo as a preferred source to see more of our stories on Google. Two years after learning she had breast cancer, actress Olivia Munn says her mom, Kim Schmid, has also been diagnosed. In a ...
NEW YORK, N.Y. (WPVI) -- Tuesday is Diabetes Alert Day, a day to sound the alarm about the growing number of people living with type 2 diabetes. There are millions of Americans who have type 2 ...
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a large, multi-center prospective study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results